![Sohanya Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sohanya Cheng
Corporate Officer/Principal chez
KARYOPHARM THERAPEUTICS INC.
Fortune : 1 M $ au 30/06/2026
Profil
Sohanya Cheng is currently Chief Commercial Officer at Karyopharm Therapeutics, Inc. since 2021.
Former positions include Independent Director at Carisma Therapeutics, Inc. from 2024 to 2025, VP, Head-Marketing & Corporate Affairs at Arrowhead Pharmaceuticals, Inc. in 2020, and Executive Director & Head-National Sales Force at Amgen, Inc. from 2019 to 2020.
Education includes undergraduate and graduate degrees from the University of Cambridge and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 107 940 ( 0,48 % ) | 1 M $ | 30/06/2026 | |
| 31/05/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Sohanya Cheng
| Sociétés | Poste | Début |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 10/01/2022 |
Anciens postes connus de Sohanya Cheng
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/12/2025 |
| ARROWHEAD PHARMACEUTICALS, INC. | Sales & Marketing | 01/12/2020 |
| AMGEN INC. | Sales & Marketing | 01/08/2020 |
Formation de Sohanya Cheng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
Choisissez Zonebourse 
